North America Musculoskeletal Disorders Drugs Market

North America Musculoskeletal Disorders Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Parenteral and Oral), By Drug Type (Analgesics, DMARDs, Corticosteroids), By Country and Growth Forecast, 2023 - 2029

Report Id: KBV-15585 Publication Date: May-2023 Number of Pages: 92
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support
TABLE 1 North America Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 2 North America Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Musculoskeletal Disorders Drugs Market
TABLE 4 geographical expansions – Musculoskeletal Disorders Drugs Market
TABLE 5 Acquisition and Mergers– Musculoskeletal Disorders Drugs Market
TABLE 6 Approvals and trials – Musculoskeletal Disorders Drugs Market
TABLE 7 North America Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 8 North America Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 9 North America Drug Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 10 North America Drug Stores & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 11 North America Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 12 North America Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 13 North America Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 14 North America Online Providers Market by Country, 2023 - 2029, USD Million
TABLE 15 North America Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 16 North America Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 17 North America Parenteral Market by Country, 2019 - 2022, USD Million
TABLE 18 North America Parenteral Market by Country, 2023 - 2029, USD Million
TABLE 19 North America Oral Market by Country, 2019 - 2022, USD Million
TABLE 20 North America Oral Market by Country, 2023 - 2029, USD Million
TABLE 21 North America Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 22 North America Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 23 North America Analgesics Market by Country, 2019 - 2022, USD Million
TABLE 24 North America Analgesics Market by Country, 2023 - 2029, USD Million
TABLE 25 North America DMARDs Market by Country, 2019 - 2022, USD Million
TABLE 26 North America DMARDs Market by Country, 2023 - 2029, USD Million
TABLE 27 North America Corticosteroids Market by Country, 2019 - 2022, USD Million
TABLE 28 North America Corticosteroids Market by Country, 2023 - 2029, USD Million
TABLE 29 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 30 North America Others Market by Country, 2023 - 2029, USD Million
TABLE 31 North America Musculoskeletal Disorders Drugs Market by Country, 2019 - 2022, USD Million
TABLE 32 North America Musculoskeletal Disorders Drugs Market by Country, 2023 - 2029, USD Million
TABLE 33 US Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 34 US Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 35 US Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 36 US Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 37 US Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 38 US Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 39 US Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 40 US Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 41 Canada Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 42 Canada Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 43 Canada Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 44 Canada Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 45 Canada Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 46 Canada Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 47 Canada Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 48 Canada Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 49 Mexico Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 50 Mexico Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 51 Mexico Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 52 Mexico Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 53 Mexico Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 54 Mexico Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 55 Mexico Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 56 Mexico Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 57 Rest of North America Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 58 Rest of North America Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 59 Rest of North America Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 60 Rest of North America Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 61 Rest of North America Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 62 Rest of North America Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 63 Rest of North America Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 64 Rest of North America Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 65 Key information –Johnson & Johnson
TABLE 66 Key Information – Pfizer, Inc.
TABLE 67 Key information – AbbVie, Inc.
TABLE 68 Key Information – UCB S.A.
TABLE 69 Key Information – Amgen, Inc.
TABLE 70 Key Information – Eli Lilly And Company
TABLE 71 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 72 KEY INFORMATION - Merck & Co., Inc.
TABLE 73 Key Information – Novartis AG
TABLE 74 Key Information – Teva Pharmaceuticals Industries Ltd.

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 4 North America Musculoskeletal Disorders Drugs Market Share by Distribution Channel, 2022
FIG 5 North America Musculoskeletal Disorders Drugs Market Share by Distribution Channel, 2029
FIG 6 North America Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2029, USD Million
FIG 7 North America Musculoskeletal Disorders Drugs Market Share by Route of Administration, 2022
FIG 8 North America Musculoskeletal Disorders Drugs Market Share by Route of Administration, 2029
FIG 9 North America Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2029, USD Million
FIG 10 North America Musculoskeletal Disorders Drugs Market Share by Drug Type, 2022
FIG 11 North America Musculoskeletal Disorders Drugs Market Share by Drug Type, 2029
FIG 12 North America Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2029, USD Million
FIG 13 North America Musculoskeletal Disorders Drugs Market Share by Country, 2022
FIG 14 North America Musculoskeletal Disorders Drugs Market Share by Country, 2029
FIG 15 North America Musculoskeletal Disorders Drugs Market by Country, 2019 - 2029, USD Million
FIG 16 SWOT analysis: Johnson & Johnson
FIG 17 Recent strategies and developments: Pfizer, Inc.
FIG 18 Recent strategies and developments: AbbVie, Inc.
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo